Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Opinion in Immunology|July 12, 2015
Engineering antigen-specific immunological toleranceStephan Kontos, Alizée J Grimm, Jeffrey A HubbellScientific Reports|October 30, 2015
Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigensAlizée J Grimm, Stephan Kontos, Giacomo Diaceri, et al.Trends in Cancer|September 28, 2024
Crosstalk of T cells within the ovarian cancer microenvironmentBovannak S Chap, Nicolas Rayroux, Alizée J Grimm, et al.Current Opinion in Biotechnology|April 26, 2020
Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?Silvia Martin-Lluesma, Michele Graciotti, Alizée J Grimm, et al.Vaccine|March 27, 2016
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responsesZiad Julier, Alexandre de Titta, Alizée J Grimm, et al.Nature Reviews. Clinical Oncology|September 4, 2024
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approachEleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.Pageof 2